Research Topics
| Catherine SeylerSummaryCountry: France Publications
| Collaborators
|
Detail Information
Publications
Impact of genotypic drug resistance mutations on clinical and immunological outcomes in HIV-infected adults on HAART in West AfricaCatherine Seyler
INSERM U593, Universite Victor Segalen Bordeaux 2, 146 rue Leo Saignat, 33076 Bordeaux, France
AIDS 21:1157-64. 2007..To analyse the association between the presence of resistance mutations and treatment outcomes. The impact of HIV-1 drug resistance mutations in African adults on HAART has so far never been reported...
Morbidity before and after HAART initiation in Sub-Saharan African HIV-infected adults: a recurrent event analysisCatherine Seyler
Programme PAC CI, Abidjan, Cote d Ivoire
AIDS Res Hum Retroviruses 23:1338-47. 2007..In HIV-infected patients on ART, the incidence of severe morbidity varied with the past history of morbidity. The past history of morbidity should be taken into account when comparing HIV morbidity rates before and after ART initiation...
Anthropometric and immunological success of antiretroviral therapy and prediction of virological success in west African adultsEugene Messou
Programme PAC, CI, Abidjan, Cote d Ivoire
Bull World Health Organ 86:435-42. 2008..We assessed the gain or loss in body mass index (BMI), alone or in combination with the gain or loss in CD4+ T-cell count (CD4), as a tool for predicting the response to ART...
Risk factors for active tuberculosis after antiretroviral treatment initiation in AbidjanCatherine Seyler
INSERM U593, , , 33076 Bordeaux, France
Am J Respir Crit Care Med 172:123-7. 2005..If confirmed by others, this finding could lead to assessment of new patterns of time-limited tuberculosis secondary chemoprophylaxis during the period of initiation of HAART in sub-Saharan African adults...
Rapid scaling-up of antiretroviral therapy in 10,000 adults in Côte d'Ivoire: 2-year outcomes and determinantsSiaka Toure
Aconda Association, Abidjan, Cote d Ivoire
AIDS 22:873-82. 2008..To assess the rates and determinants of mortality, loss to follow-up and immunological failure in a nongovernmental organization-implemented program of access to antiretroviral treatment in Côte d'Ivoire...
Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West AfricaRaoul Moh
Trivacan ANRS 1269 study group, Abidjan, France
AIDS 21:2483-91. 2007..To estimate the incidence and risk factors of mortality and severe morbidity during the first months following antiretroviral therapy (ART) initiation in West African adults...
Occult HBV infection in untreated HIV-infected adults in Côte d'IvoireThérèse N'Dri-Yoman
Programme PAC CI, Abidjan, Cote d Ivoire
Antivir Ther 15:1029-34. 2010..Here, we estimated the prevalence of untreated HIV-infected adults with negative serum HBsAg and detectable plasma HBV DNA in Côte d'Ivoire...
Antiretroviral treatment changes in adults from Côte d'Ivoire: the roles of tuberculosis and pregnancyEugene Messou
INSERM U897, Universite Victor Segalen Bordeaux 2, Bordeaux, France
AIDS 24:93-9. 2010..To determine the rates and causes of first antiretroviral treatment changes in HIV-infected adults in Côte d'Ivoire...
High incidence of atypical mycobacteriosis in African HIV-infected adults with low CD4 cell counts: a 6-year cohort study in Côte d'IvoireDominique Bonard
Programme PAC-CI, Abidjan, , France
AIDS 18:1961-4. 2004..In sub-Saharan Africa, where most patients start highly active antiretroviral therapy with low CD4 cell counts, improving the diagnosis of NTM may be relevant...
Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaborationPaula Braitstein
Department of Medicine, Indiana University, Indianapolis, Indiana, USA
J Womens Health (Larchmt) 17:47-55. 2008....
The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d'IvoireElena Losina
Department of Biostatistics and Epidemiology, Boston University School of Public Health, Boston, MA, USA
Antivir Ther 12:543-51. 2007..Studies in developed countries have shown highly active antiretroviral therapy (HAART) decreases incidence of severe opportunistic diseases (ODs) in HIV-infected patients beyond that which is expected from changes in CD4+ T-cell count...
Scaling up antiretroviral therapy in South Africa: the impact of speed on survivalRochelle P Walensky
The Divisions of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA
J Infect Dis 197:1324-32. 2008..Only 33% of eligible human immunodeficiency virus (HIV)-infected patients in South Africa receive antiretroviral therapy (ART). We sought to estimate the impact of alternative ART scale-up scenarios on patient outcomes from 2007-2012...
Pattern of bacterial diseases in a cohort of HIV-1 infected adults receiving cotrimoxazole prophylaxis in Abidjan, Côte d'IvoireXavier Anglaret
INSERM U330, , Bordeaux, France
AIDS 17:575-84. 2003..1/100 PY), serious bacterial morbidity remains the first cause of hospital admission in adults receiving cotrimoxazole in this setting...
Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, Côte d'IvoireCatherine Seyler
Programme PAC-CI, Abidjan,
Antivir Ther 8:385-93. 2003..CONCLUSION: Medium-term survival under ART may be as good in Africa as in industrialized countries, provided that patients benefit from access to care for opportunistic infections, including bacterial diseases, tuberculosis and malaria...
Impact of vital status investigation procedures on estimates of survival in cohorts of HIV-infected patients from Sub-Saharan AfricaXavier Anglaret
INSERM U 593, Universite Victor Segalen, Bordeaux, France
J Acquir Immune Defic Syndr 35:320-3. 2004..We suggest that the percentage of deaths known through VSIPs would be a useful indicator to be added when reporting survival data from urban HIV cohort studies in sub-Saharan Africa...
Nonantiretroviral drug consumption by CD4 cell count in HIV-infected adults: a 5-year cohort study in Côte d'IvoireNohelly Nombela
Unité INSERM U 593, Universite Victor Segalen, Bordeaux, Cedex, France
J Acquir Immune Defic Syndr 41:225-31. 2006..Meanwhile, they roughly suggest that successful antiretroviral treatment, which would stabilize the CD4 count above 500 cells/mm, could reduce by 5-fold the cost of nonantiretroviral drugs in HIV-infected adults in Abidjan...
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countriesPaula Braitstein
Lancet 367:817-24. 2006..Timely diagnosis and assessment of treatment eligibility, coupled with free provision of HAART, might reduce this excess mortality...
Incidence of neutropenia in HIV-infected African adults receiving co-trimoxazole prophylaxis: a 6-year cohort study in Abidjan, Côte d'IvoireSiaka Toure
, , , 33076 Bordeaux Cedex, France
Trans R Soc Trop Med Hyg 100:785-90. 2006..The consequences of associating co-trimoxazole with other haematotoxic drugs should be carefully assessed...
Risk factors for active tuberculosis in adults on highly active antiretroviral therapy in AfricaCatherine Seyler
AIDS 20:1463; author reply 1463-5. 2006
Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settingsGraeme Meintjes
Institute of Infectious Diseases and Molecular Medicine and Department of Medicine, University of Cape Town, Cape Town, South Africa
Lancet Infect Dis 8:516-23. 2008..It is envisaged that these definitions could be used by clinicians and researchers in a variety of settings to promote standardisation and comparability of data...
Urinary pH in HIV-infected adults in Ivory Coast and in FranceEmmanuel Mortier
AIDS 17:2003-5. 2003
Are a past history of tuberculosis and WHO clinical stage associated with incident tuberculosis in adults receiving antiretroviral therapy?, reply to Lawn et alEric Ouattara
AIDS 21:389-90. 2007
